SI1572699T1 - Kristalne soli cefdinira - Google Patents

Kristalne soli cefdinira

Info

Publication number
SI1572699T1
SI1572699T1 SI200330704T SI200330704T SI1572699T1 SI 1572699 T1 SI1572699 T1 SI 1572699T1 SI 200330704 T SI200330704 T SI 200330704T SI 200330704 T SI200330704 T SI 200330704T SI 1572699 T1 SI1572699 T1 SI 1572699T1
Authority
SI
Slovenia
Prior art keywords
salts
cefdinir
crystalline cefdinir
cefdinir salts
formula
Prior art date
Application number
SI200330704T
Other languages
English (en)
Inventor
Giovanni Pozzi
Gomez Patricio Martin
Marco Alpegiani
Walter Cabri
Original Assignee
Antibioticos Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antibioticos Spa filed Critical Antibioticos Spa
Publication of SI1572699T1 publication Critical patent/SI1572699T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200330704T 2002-12-20 2003-12-01 Kristalne soli cefdinira SI1572699T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT002724A ITMI20022724A1 (it) 2002-12-20 2002-12-20 Sali cristallini del cefdinir.
EP03789109A EP1572699B1 (en) 2002-12-20 2003-12-01 Crystalline cefdinir salts
PCT/EP2003/013524 WO2004056835A1 (en) 2002-12-20 2003-12-01 Crystalline cefdinir salts

Publications (1)

Publication Number Publication Date
SI1572699T1 true SI1572699T1 (sl) 2007-06-30

Family

ID=32676853

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330704T SI1572699T1 (sl) 2002-12-20 2003-12-01 Kristalne soli cefdinira

Country Status (12)

Country Link
US (1) US7173126B2 (sl)
EP (1) EP1572699B1 (sl)
JP (1) JP2006511561A (sl)
AT (1) ATE353903T1 (sl)
AU (1) AU2003293746A1 (sl)
DE (1) DE60311869T2 (sl)
DK (1) DK1572699T3 (sl)
ES (1) ES2281685T3 (sl)
IT (1) ITMI20022724A1 (sl)
PT (1) PT1572699E (sl)
SI (1) SI1572699T1 (sl)
WO (1) WO2004056835A1 (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
EP1842852A1 (en) 2002-08-13 2007-10-10 Sandoz AG A cefdinir intermediate
ITMI20022076A1 (it) * 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
CN100357294C (zh) * 2003-03-24 2007-12-26 桑多斯股份公司 7－[2－(2－氨基噻唑－4－基)－2－羟基亚氨基乙酰胺－3－乙烯基－3－头孢烯－4－羧酸(顺式异构体)的新型晶体和其制备方法
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
MX2007006018A (es) * 2004-11-30 2007-06-07 Astellas Pharma Inc Suspension farmaceutica oral novedosa de cristal de cefdinir.
WO2006117794A1 (en) * 2005-05-02 2006-11-09 Hetero Drugs Limited A novel crystalline form of cefdinir
EP1899356A1 (en) * 2005-06-15 2008-03-19 Hetero Drugs Limited Cefdinir process
EP1828208A2 (en) * 2005-10-31 2007-09-05 Teva Pharmaceutical Industries Ltd Crystalline form of cefdinir cesium salt
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
CN101481383B (zh) * 2008-12-31 2012-01-11 杭州奥默医药技术有限公司 头孢地尼酸式复盐化合物及制备方法
CN103012433B (zh) * 2012-12-13 2015-06-24 珠海保税区丽珠合成制药有限公司 头孢地尼晶型b的制备方法
CN103319503A (zh) * 2013-06-09 2013-09-25 四川方向药业有限责任公司 一种头孢地尼的制备方法
CN111635419B (zh) * 2020-07-13 2022-05-24 广药白云山化学制药(珠海)有限公司 一种头孢地尼精制母液的处理方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3757014A (en) 1971-05-07 1973-09-04 Bristol Myers Co Ts 1,3,4 - oxadiazol-2-yl)thiomethyl)-3-cephem-4-carboxylic acid and sal7-(d-(alpha-amino-alpha-pheyle-acetamido)) - 3-(s-(5-hydroxymethyl -
JPH0674276B2 (ja) * 1987-08-19 1994-09-21 藤沢薬品工業株式会社 ７−［２−（２−アミノチアゾール−４−イル）−２−ヒドロキシイミノアセトアミド−３−ビニル−３−セフェム−４−カルボン酸（シン異性体）の新規結晶
ZA885709B (en) * 1987-08-19 1989-04-26 Fujisawa Pharmaceutical Co Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
WO1992007840A1 (en) * 1990-11-02 1992-05-14 Taisho Pharmaceutical Co., Ltd. Thiazole thioester derivative
AT405283B (de) * 1997-04-04 1999-06-25 Biochemie Gmbh Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
IT1317735B1 (it) * 2000-01-26 2003-07-15 Nicox Sa Sali di agenti antimicrobici.
JP4544692B2 (ja) * 2000-04-13 2010-09-15 大塚化学株式会社 ３−ビニル−セフェム化合物の製造方法
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
BR0215709A (pt) * 2002-04-26 2005-03-29 Ranbaxy Lab Ltd Processo para a preparação de cefdinir
EP1842852A1 (en) * 2002-08-13 2007-10-10 Sandoz AG A cefdinir intermediate
GB0416379D0 (en) * 2004-07-22 2004-08-25 Sandoz Ag Organic compounds

Also Published As

Publication number Publication date
AU2003293746A1 (en) 2004-07-14
DK1572699T3 (da) 2007-06-11
EP1572699A1 (en) 2005-09-14
JP2006511561A (ja) 2006-04-06
EP1572699B1 (en) 2007-02-14
ITMI20022724A1 (it) 2004-06-21
PT1572699E (pt) 2007-05-31
US20060074236A1 (en) 2006-04-06
ATE353903T1 (de) 2007-03-15
WO2004056835A1 (en) 2004-07-08
DE60311869T2 (de) 2007-09-20
US7173126B2 (en) 2007-02-06
DE60311869D1 (de) 2007-03-29
ES2281685T3 (es) 2007-10-01

Similar Documents

Publication Publication Date Title
SI1572699T1 (sl) Kristalne soli cefdinira
ATE450514T1 (de) Piperazinylalkylpyrazol-derivate zur verwendung als selektive calciumkanalblocker des t-typs und verfahren zu ihrer herstellung
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
HRP20080274T3 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
MXPA06010097A (es) Inhibidores de dipeptidil peptidasa-iv.
WO2008138126A8 (en) Bicyclic pyrimidine derivatives as calcium channel blockers
UA84460C2 (ru) Применение сульфонилкарбамидов для борьбы с нежелательным ростом растений в культурах бобовых
EP1725536B8 (en) Imidazoline derivatives having cb1-antagonistic activity
WO2007118323A8 (en) Isoxazole derivatives as calcium channel blockers
MX2008010884A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200719889A (en) Amino acid derivatives
EP1532131A4 (en) COMPOUNDS OF THE MOTILID TYPE
WO2004087700A8 (fr) Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
IL183271A0 (en) Crystalline form of cefdinir ammonium salt as an intermediate for the preparation of pure cefdinir
UA96149C2 (en) Method for producing 4-oxoquinoline compound
ID26210A (id) Proses pemurnian turunan sefalosporin
MX2007014297A (es) Derivados de purina y su uso para el tratamiento de enfermedades autoinmunes.
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
BRPI0411245A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de vìrus oncogênicos e para tratamento ou profilaxia de condições ou distúrbios devidos a infecção por hpv
TW200640888A (en) [1,2,4]-dithiazoli (di) ne derivatives, inducers of glutha-thione-S-transferase and NADPH quinone oxido-reduc-tase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
PL2057148T3 (pl) Amidynowe pochodne 2-heteroarylochinazolin i chinolin, silne środki przeciwbólowe i środki przeciwzapalne